V013-2677 Screening compound: N-[(2H-1,3-benzodioxol-5-yl)methyl]-5-[2-(2,4-difluorophenyl)acetyl]-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine-3-carboxamide

V013-2677 Screening compound: N-[(2H-1,3-benzodioxol-5-yl)methyl]-5-[2-(2,4-difluorophenyl)acetyl]-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine-3-carboxamide
V013-2677 Screening compound: N-[(2H-1,3-benzodioxol-5-yl)methyl]-5-[2-(2,4-difluorophenyl)acetyl]-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine-3-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V013-2677
N-[(2H-1,3-benzodioxol-5-yl)methyl]-5-[2-(2,4-difluorophenyl)acetyl]-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine-3-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V013-2677

Molecular Formula

C23H20F2N4O4 (C23 H20 F2 N4 O4)

Compound Name

N-[(2H-1,3-benzodioxol-5-yl)methyl]-5-[2-(2,4-difluorophenyl)acetyl]-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine-3-carboxamide

IUPAC name

N-[(2H-13-benzodioxol-5-yl)methyl]-5-[2-(24-difluorophenyl)acetyl]-1H4H5H6H7H-pyrazolo[43-c]pyridine-3-carboxamide

SMILES

O=C(Cc(ccc(F)c1)c1F)N(CC1)Cc2c1[nH]nc2C(NCc(cc1)cc2c1OCO2)=O

InChI

InChI=1S/C23H20F2N4O4/c24-15-3-2-14(17(25)9-15)8-21(30)29-6-5-18-16(11-29)22(28-27-18)23(31)26-10-13-1-4-19-20(7-13)33-12-32-19/h1-4,7,9H,5-6,8,10-12H2,(H,26,31)(H,27,28)

InChI Key

IMAYFBVLBMIDGO-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD20032614

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

454.43

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.557

Distribution Coefficient, logD

2.557

Water Solubility, LogSw

-2.93

Polar Surface Area

82.583

Acid Dissociation Constant (pKa)

6.74

Base Dissociation Constant (pKb)

1.77

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

26.10

V013-2677 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V013-2677 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V013-2677?
Check Price and Availability of V013-2677, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V013-2677 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V013-2677
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V013-2677
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V013-2677 available by request